Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19 Industry News July 6, 2023 …
Capacity Building: Plans for a Public Health Emergency Operations Center in Armenia Contracts + Grants July 5, 2023 …
UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness Contracts + Grants May 26, 2023 …
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance Antimicrobial Resistance April 26, 2023 …
Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding Contracts + Grants January 25, 2023 …
Political Interference: White House Launches Framework to Protect Scientific Integrity Policy + Initiatives January 13, 2023 …
DARPA Selects Teams to Develop Vaccine Durability Prediction Model Medical Countermeasures January 13, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies Medical Countermeasures January 12, 2023 …
Protection from Biothreats: DOD to Modernize Medical Countermeasures Development CBRNE January 10, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
How Organ-on-a-chip Models Could Grease the Drug Development Pipeline Medical Countermeasures January 10, 2023 …
